Related references
Note: Only part of the references are listed.Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α-Synuclein
Poul Henning Jensen et al.
MOVEMENT DISORDERS (2023)
Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease
Robert Brendza et al.
NEUROBIOLOGY OF DISEASE (2023)
Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease
Yiming Li et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut
Jacqui T. Nimmo et al.
ACTA NEUROPATHOLOGICA (2022)
Passive Immunization in Alpha-Synuclein Preclinical Animal Models
Jonas Folke et al.
BIOMOLECULES (2022)
Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies
Dhanya Vijayakumar et al.
CNS DRUGS (2022)
A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine
Hui Jing Yu et al.
MOVEMENT DISORDERS (2022)
Conformation-specific Antibodies Targeting Aggregated Forms of α-synuclein Block the Propagation of Synucleinopathy
Minsun Choi et al.
EXPERIMENTAL NEUROBIOLOGY (2022)
A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties
Michael Fassler et al.
CELLS (2022)
Trial of Prasinezumab in Early-Stage Parkinson's Disease
G. Pagano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Trial of Cinpanemab in Early Parkinson's Disease
A. E. Lang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Yemima R. Butler et al.
NATURE COMMUNICATIONS (2022)
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
Sahar Roshanbin et al.
PHARMACEUTICS (2022)
Alzheimer's disease failed clinical trials
Shreya Asher et al.
LIFE SCIENCES (2022)
Treating Parkinson's Disease with Antibodies: Previous Studies and Future Directions
Anne-Marie Castonguay et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction
Renee C. Gentzel et al.
NEUROBIOLOGY OF AGING (2021)
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
Eva Nordstrom et al.
NEUROBIOLOGY OF DISEASE (2021)
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study
Werner Poewe et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Amyloid-beta and alpha-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials
Jacqui Taryn Nimmo et al.
FRONTIERS IN NEUROSCIENCE (2021)
Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
Yun-Hsiang Chen et al.
GENES (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease
Luis M. A. Oliveira et al.
NPJ PARKINSONS DISEASE (2021)
Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs
Amulya Nidhi Shrivastava et al.
BIOPHYSICAL JOURNAL (2020)
Characterization of novel conformation-selective alpha-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease
Michael X. Henderson et al.
NEUROBIOLOGY OF DISEASE (2020)
The emerging role of ?-synuclein truncation in aggregation and disease
Zachary A. Sorrentino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
A Small-Molecule-Responsive Riboswitch Enables Conditional Induction of Viral Vector-Mediated Gene Expression in Mice
Benjamin Strobel et al.
ACS SYNTHETIC BIOLOGY (2020)
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
Jacqui T. Nimmo et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
Sireesha Manne et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
Influence of Normal Aging on Brain Autophagy: A Complex Scenario
David A. Loeffler
FRONTIERS IN AGING NEUROSCIENCE (2019)
Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs
Benjamin Strobel et al.
HUMAN GENE THERAPY METHODS (2019)
α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling
Mingzhu Huang et al.
FRONTIERS IN NEUROSCIENCE (2019)
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
Frances H. Priddy et al.
LANCET HIV (2019)
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
Andreas Weihofen et al.
NEUROBIOLOGY OF DISEASE (2019)
The physiological role of α-synuclein and its relationship to Parkinson's Disease
David Sulzer et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
Miroslaw Brys et al.
MOVEMENT DISORDERS (2019)
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian et al.
NATURE NEUROSCIENCE (2019)
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
Darren J. Schofield et al.
NEUROBIOLOGY OF DISEASE (2019)
Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo
Owen Scudamore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS
Jerusha Naidoo et al.
MOLECULAR THERAPY (2018)
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents
Nicole K. Polinski et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease A Randomized Clinical Trial
Joseph Jankovic et al.
JAMA NEUROLOGY (2018)
Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathology
Amanda N. Sacino et al.
JOURNAL OF NEUROCHEMISTRY (2017)
First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk et al.
MOVEMENT DISORDERS (2017)
Therapeutic approaches to target alpha-synuclein pathology
Patrik Brundin et al.
EXPERIMENTAL NEUROLOGY (2017)
Selective imaging of internalized proteopathic α-synuclein seeds in primary neurons reveals mechanistic insight into transmission of synucleinopathies
Richard J. Karpowicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
Christina Ising et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin et al.
JOURNAL OF NEUROSCIENCE (2017)
Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
Zachary A. Sorrentino et al.
MOLECULAR NEURODEGENERATION (2017)
Neuropathology of Genetic Synucleinopathies With Parkinsonism: Review of the Literature
Susanne A. Schneider et al.
MOVEMENT DISORDERS (2017)
Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
Mohammad Shahnawaz et al.
JAMA NEUROLOGY (2017)
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins
William P. Flavin et al.
ACTA NEUROPATHOLOGICA (2017)
Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice
Wencheng Liu et al.
JOURNAL OF NEUROSCIENCE (2016)
Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
Graham Fairfoul et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
Sebastian P. Fuchs et al.
PLOS ONE (2016)
Structural and functional properties of prefibrillar α-synuclein oligomers
Laura Pieri et al.
SCIENTIFIC REPORTS (2016)
Nanomechanical properties of distinct fibrillar polymorphs of the protein α-synuclein
Ali Makky et al.
SCIENTIFIC REPORTS (2016)
Antibody Delivery Mediated by Recombinant Adeno-associated Virus for the Treatment of Various Chronic and Infectious Diseases
Marc-Andre Robert et al.
CURRENT GENE THERAPY (2016)
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies
Nga Bien-Ly et al.
NEURON (2015)
Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging
Niklas K. U. Koehler et al.
PLOS ONE (2015)
Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
Karina J. Vargas et al.
JOURNAL OF NEUROSCIENCE (2014)
Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
Veronica Lindstrom et al.
NEUROBIOLOGY OF DISEASE (2014)
Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice
Amanda N. Sacino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
John F. Kellie et al.
SCIENTIFIC REPORTS (2014)
Brain-wide pathway for waste clearance captured by contrast-enhanced MRI
Jeffrey J. Iliff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
SNCA: Major genetic modifier of age at onset of Parkinson's disease
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2013)
100 years of Lewy pathology
Michel Goedert et al.
NATURE REVIEWS NEUROLOGY (2013)
Garbage Truck of the Brain
Maiken Nedergaard
SCIENCE (2013)
Structural and functional characterization of two alpha-synuclein strains
Luc Bousset et al.
NATURE COMMUNICATIONS (2013)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
Sarah Jesse et al.
JOURNAL OF NEUROLOGY (2011)
Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy
Sook K. Song et al.
NEUROBIOLOGY OF AGING (2011)
Anatomy and physiology of cerebrospinal fluid
L. Sakka et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2011)
αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction
Becket Greten-Harrison et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies
Manuela Neumann et al.
ACTA NEUROPATHOLOGICA (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice
Christian Freichel et al.
NEUROBIOLOGY OF AGING (2007)
Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease
Ken-ichiro Fukuchi et al.
NEUROBIOLOGY OF DISEASE (2006)
PA700, the regulatory complex of the 26S proteasome, interferes with α-synuclein assembly
M Ghee et al.
FEBS JOURNAL (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Dynamics of brain-derived proteins in cerebrospinal fluid
H Reiber
CLINICA CHIMICA ACTA (2001)
Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells
M Encinas et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain
PJ Kahle et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
